Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China · Delayed Price · Currency is CNY 15.96
-0.13 (-0.81%)
Apr 30, 2026, 3:00 PM CST
SHA:603079 Revenue
Zhejiang Shengda Bio-Pharm had revenue of 189.22M CNY in the quarter ending March 31, 2026, a decrease of -6.89%. This brings the company's revenue in the last twelve months to 830.53M, down -1.81% year-over-year. In the year 2025, Zhejiang Shengda Bio-Pharm had annual revenue of 844.54M with 2.07% growth.
Revenue (ttm)
830.53M
Revenue Growth
-1.81%
P/S Ratio
3.60
Revenue / Employee
802.44K
Employees
1,035
Market Cap
2.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 844.54M | 17.13M | 2.07% |
| Dec 31, 2024 | 827.40M | 100.00M | 13.75% |
| Dec 31, 2023 | 727.41M | -10.61M | -1.44% |
| Dec 31, 2022 | 738.02M | -51.71M | -6.55% |
| Dec 31, 2021 | 789.73M | -77.58M | -8.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition